Assembly Biosciences, Inc. Proceeds from Sale of Held-to-maturity Securities
Assembly Biosciences, Inc. (ASMB) reported Proceeds from Sale of Held-to-maturity Securities of $500.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities · last filed 2019-08-05
- Assembly Biosciences, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2019-06-30 was $0.00.
- Assembly Biosciences, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2019-03-31 was $500.00K.
- Assembly Biosciences, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2018-06-30 was $0.00.
- Assembly Biosciences, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2018-03-31 was $0.00.
| Period end | Proceeds from Sale of Held-to-maturity Securities 3 month | Proceeds from Sale of Held-to-maturity Securities 6 month |
|---|---|---|
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $500.00K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $500.00K 10-Q · filed 2019-05-09 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |